ETIOTROPIC THERAPY FOR ACUTE RESPIRATORY VIRAL INFECTIONS WITH STENOSING LARYNGOTRACHEITIS

Clinical-laboratory analysis of the effectiveness of VIFERON® (suppositories rectal) in children from 1 month up to 7 years with acute respiratory viral infections (ARVI), accompanied by acute stenosing laryngotracheitis (ASLT), hospitalized in Children's City Clinical Hospital №5 named after N.F. Filatov. We have found that the drug VIFERON® helps statistically significant reduction in the duration of all major clinical manifestations of the disease as a whole, and also reduces the severity and duration of clinical symptoms ASLT, and significantly contributes to the faster elimination of viral antigens.